CSIMarket Company Name, Ticker, Competitors, else..
 
Rockwell Medical inc   (NASDAQ: RMTI)
 
Price: $8.3200 $0.28 3.483%
Day's High: $8.34000015258789 Week Perf: 4.13 %
Day's Low: $ 7.87 30 Day Perf: 10.79 %
Volume (M): 27,463 52 Wk High: $ 8.50
Volume (M$): $ 0 52 Wk Avg: $2.22
Open: $7.87 52 Wk Low: $0.55



 Market Capitalization (Millions $) 33
 Shares Outstanding (Millions) 4
 Employees 157
 Revenues (TTM) (Millions $) 70
 Net Income (TTM) (Millions $) -5
 Cash Flow (TTM) (Millions $) -3
 Capital Exp. (TTM) (Millions $) 1

Business Description


Rockwell Medical Inc. is a pharmaceutical company that specializes in the development, manufacturing, and commercialization of medicines and medical devices for the treatment of chronic kidney disease (CKD). The company's primary focus is on providing innovative solutions to patients with kidney disorders, striving to improve their quality of life. Rockwell Medical's products include dialysis concentrates, iron replacement therapies, and hemodialysis systems. The company is committed to advancing the standard of care for CKD patients through its research and development efforts.


   Company Address: 30142 S. Wixom Road Wixom 48393 MI
   Company Phone Number: 960-9009   Stock Exchange / Ticker: NASDAQ RMTI


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ELTP   -1.88%    
MNKD   -4.29%    
PBYI   -4.89%    
TEVA   -1.47%    
TXMD   -3.57%    
VTRS   -2.95%    
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.47
Price to Sales (Expected) -
Price to Book 0.94
PEG (TTM) -

Financial Strength Current
Quick Ratio 2.23
Working Capital Ratio 3.27
Leverage Ratio (MRQ) 0.61
Total Debt to Equity 0.26
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -1.44 $
Revenues (TTM) 17.64 $
Cash Flow (TTM) -
Cash 6.3 $
Book Value 8.86 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 444,758
Net Income per Employee (TTM) -32,382
Receivable Turnover Ratio (TTM) 8.31
Inventory Turnover Ratio (TTM) 17.36
Asset Turnover Ratio (TTM) 1.2

Profitability Ratios Current
Gross Margin (MRQ) 18.24 %
Operating Margin (MRQ) -5.97 %
Net Margin (MRQ) -6.59 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Rockwell Medical Inc's Segments
Concentrate Products    30.49 % of total Revenue
United States    167.01 % of total Revenue
Non-US    30.49 % of total Revenue
Reportable    197.5 % of total Revenue

  Rockwell Medical Inc Outlook

On May 14 2024 the Rockwell Medical Inc provided following guidance

Rockwell Medical Inc. reported strong financial and operational results for the first quarter of 2024, exceeding expectations. The company also raised its guidance for the full year, reflecting its positive outlook for the future.

In the first quarter of 2024, Rockwell Medical Inc. demonstrated impressive performance across various metrics. The company's revenue showed a significant increase compared to the same period last year, reflecting strong sales and market demand for its products. Additionally, the company's operational efficiency improved, leading to higher profitability and margins.

As a result of its strong performance in the first quarter, Rockwell Medical Inc. has revised its guida...





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.